fpl-52694 has been researched along with cysteamine in 2 studies
Studies (fpl-52694) | Trials (fpl-52694) | Recent Studies (post-2010) (fpl-52694) | Studies (cysteamine) | Trials (cysteamine) | Recent Studies (post-2010) (cysteamine) |
---|---|---|---|---|---|
25 | 1 | 1 | 3,307 | 60 | 666 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Smith, JA | 1 |
2 other study(ies) available for fpl-52694 and cysteamine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The effect of atropine, cimetidine and FPL 52694 on duodenal ulcers in mice.
Topics: Animals; Anti-Ulcer Agents; Atropine; Chromones; Cimetidine; Cysteamine; Duodenal Ulcer; Female; Guanidines; Mice; Rats; Rats, Inbred Strains; Species Specificity | 1983 |